期刊
JOURNAL OF IMMUNOLOGY
卷 201, 期 8, 页码 2264-2272出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1701223
关键词
-
类别
资金
- KAKENHI grant
- Takeda Science Foundation
- Institute for Fermentation Osaka
- Mitsubishi Foundation
- Waksman Foundation of Japan
- Mochida Memorial Foundation for Medical and Pharmaceutical Research
- Takeshi Nagao Intractable Diseases Research Fund
- Tokyo Medical Research Foundation
- Japan Science and Technology Agency-Centers of Research Excellence in Science and Technology Program
- Osaka Foundation for the Promotion of Clinical Immunology
Bmi1 is a polycomb group protein and regulator that stabilizes the ubiquitination complex PRC1 in the nucleus with no evidently direct link to the NF-kappa B pathway. In this study, we report a novel function of Bmi1: its regulation of I kappa B alpha ubiquitination in the cytoplasm. A deficiency of Bmi1 inhibited NF-kappa B-mediated gene expression in vitro and a NF-kappa B-mediated mouse model of arthritis in vivo. Mechanistic analysis showed that Bmi1 associated with the SCF ubiquitination complex via its N terminus and with phosphorylation by an IKK alpha/beta-dependent pathway, leading to the ubiquitination of I kappa B alpha . These effects on NF-kappa B-related inflammation suggest Bmi1 in the SCF complex is a potential therapeutic target for various diseases and disorders, including autoimmune diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据